SIRT2, present both in nuclear and cytoplasmic compartments, can increase MFN2 and decrease DRP1, thus promoting mitochondrial fusion 104,105
doi:10.1097/00001622-200103000-00008
We've seen this pattern across hundreds of clients in medically supervised weight loss programs: patients using both formulations report fewer energy crashes, better workout recovery, and more consistent fat loss compared to those using diet and GLP-1 medication alone
By supercharging Phase II pathways, NAC ensures that the liver can safely complete the detoxification cycle without succumbing to oxidative stress
According to Leverage, a research platform funded by the Robert Wood Johnson Foundation, at least 15 states included anti-obesity drugs in their employee health plans in 2025, while nearly half the states limited coverage of GLP-1s